BioCentury
ARTICLE | Company News

ExperGen, Thallion cancer news

June 21, 2010 7:00 AM UTC

Thallion said the International Chamber of Commerce International Court of Arbitration ruled in favor of ExperGen in a dispute between the companies over a 2006 deal in which Thallion licensed TLN-232...